Dados B3 › ONCO3
ONCO3 (Oncoclínicas do Brasil): has debt gone up?
ONCO3 (Oncoclínicas do Brasil): at the end of 2025, net debt was R$ 3.3 billion; in 2024, R$ 3.6 billion.
| Year | Net debt | Net debt / EBITDA | Caveat |
|---|---|---|---|
| 2025 | R$ 3.3 billion | — | EBITDA at or below zero [ebitda_nao_positivo] |
| 2024 | R$ 3.6 billion | 17.39 | — |
| 2023 | R$ 3.8 billion | 3.74 | — |
| 2022 | R$ 2.4 billion | 3.69 | — |
| 2021 | R$ 415.6 million | 1.37 | — |
| 2020 | R$ 844.7 million | 6.68 | — |
Net debt = short- and long-term borrowings minus cash and financial investments, at year end. Negative = net cash. EBITDA = operating result plus depreciation and amortization. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/ONCO3/indicadores - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: ONCO3.
Dividends · Profit · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:14 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:14 UTC. If this does not match /saude, you are reading a cached copy.